SOMERSET, N.J., Nov. 13 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. announced today that it will host an Investor Day on Tuesday, December 11th, 2007 in New York City from 9 a.m. to noon. The meeting will provide an overview and update on inVentiv’s business, and will include senior management from across inVentiv’s four segments.
The Investor Day will be held at the offices of inVentiv’s Chandler Chicco Agency (CCA) business unit, located at 450 West 15th Street, Suite #700 in New York City. Please go to http://selectsurvey.inventivcommunications.com/TakeSurvey.aspx?SurveyID=88KI95 6 to request an invitation. Those who do not have Internet access can call (732) 537-4804.
The meeting is open to analysts and investors and will be accessible by live audio webcast on inVentiv Health’s website at http://www.inventivhealth.com/health/newsroom/webcasts.asp. Presentation slides also will be available for all participants and an archived version of the webcast will be available on inVentiv Health’s website for one week following the presentation.
To listen to the presentation live, please dial 800-358-8448 (Domestic) or 706-634-1367 (International). A replay of the call will be available immediately following the call through December 18, 2007 at 800-642-1687 (Domestic) or 706-645-9291 (International). The conference ID number for the replay is 23949575.
About inVentiv Health
inVentiv Health, Inc. is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health’s client roster is comprised of more than 275 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health’s performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
CONTACT: Media - Marcia Frederick of inVentiv Health, Inc.,
+1-614-543-6281, mfrederick@inventivhealth.com; Investors/Corporate - David
Bassin, CFO of inVentiv Health, Inc., +1-732-537-4804,
investor@inventivhealth.com
Web site: http://www.inventivhealth.com/
